| Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models SM Lim, SD Yang, S Lim, SG Heo, S Daniel, A Markovets, R Minoo, ... Therapeutic Advances in Medical Oncology 14, 17588359221079125, 2022 | 12 | 2022 |
| Knockdown and Inhibition of Spleen Tyrosine Kinase Decreases mTORC1 Activity and Enhances Lysosomal Biogenesis and Autolysosomal Maturation in Pancreatic Cancer Cell Lines M Pan, K Hua, A Villait, A Zuger, M Rafati, R Chen, A Singh The FASEB Journal 36, 2022 | | 2022 |
| Identification of a novel immunosuppressive myeloid gene expression signature for clinical biomarker development SS Srinivasan, G Kar, DL Russell, P Gathungu, M Rafati, D Whitston, ... Cancer Research 81 (13_Supplement), 390-390, 2021 | | 2021 |
| SYK kinase inhibition causes autophagy pathway activation via suppression of mTORC1 in KRAS-mutant pancreatic cancer cells. KL Hua, M Pan, M Rafati, A Singh MOLECULAR CANCER RESEARCH 18 (10), 30-30, 2020 | | 2020 |
| Abstract A02: SYK kinase inhibition causes autophagy pathway activation via suppression of mTORC1 in KRAS-mutant pancreatic cancer cells KL Hua, M Pan, M Rafati, A Singh Molecular Cancer Research 18 (10_Supplement), A02-A02, 2020 | | 2020 |
| Knockdown and Inhibition of SYK Tyrosine Kinase Decreases mTORC1 Activity and Enhances Lysosomal Biogenesis and Autolysosomal Maturation in Pancreatic Cancer Cell Lines M Pan, K Hua, A Villait, A Zuger, M Rafati, R Chen, S Liu, A Singh The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
